Compare Cassava Sciences Inc (FLNA) vs Marriott International Inc (MAR) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Cassava Sciences Inc vs Marriott International Inc — how do they compare? Cassava Sciences Inc trades at $0.97 (market cap $47.75M), while Marriott International Inc trades at $349.48 (market cap $90.86B). The key difference: Marriott International Inc is far larger — about 1902.8× Cassava Sciences Inc's market cap, and Marriott International Inc pays a 0.84% dividend while Cassava Sciences Inc pays none. Which is the better fit depends on your goals.
| FLNA | MAR | |
|---|---|---|
Market Cap | $47.75M | $90.86B |
Sector | Health | Consumer Cyclical |
52-Week High | $4.64 | $402.54 |
52-Week Low | $0.87 | $259.04 |
Enterprise Value | -$34.93M | $108.17B |
Dividend Yield | — | 0.84% |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
FLNA trades at $0.995, up 3.75% today, with a bearish technical signal from moving averages but neutral oscillators. The company reported three consecutive quarterly earnings beats, with Q2 2026 EPS of -$0.18 beating expectations of -$0.225. Financials show negative cash flows and profitability, with ROE at -55.79% and net income of -$90.97M in 2025. Analyst consensus is strongly positive with 8 buy ratings out of 12.
Despite operational losses, FLNA's consistent earnings beats and strong analyst support suggest potential upside if clinical developments progress. Key risks include sustained cash burn, lack of revenue, and dependence on successful drug trials for Tuberous Sclerosis Complex. The stock remains speculative with high volatility expected.
No Aura AI signal available yet.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
About Cassava Sciences Inc
Cassava Sciences Inc is a clinical-stage biotechnology company engaged in developing a scientific approach for the treatment and detection of Alzheimer's disease. Its therapeutic product candidate is called simufilam, and it is a novel treatment for Alzheimer's disease
Read more on FLNA →About Marriott International Inc
Marriott International Inc. of Maryland is a worldwide operator and franchisor of hotels. The Company franchises lodging facilities and vacation timesharing resorts under various brand names. Marriott also provides services to home and condominium owner associations for projects associated with several of its brands.
Read more on MAR →
